| 000 | 01199 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250512131751.0 | ||
| 264 | 0 | _c19680508 | |
| 008 | 196805s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1002/cpt196892204 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHollister, L E | |
| 245 | 0 | 0 |
_aBlood levels of pentobarbital sodium, meprobamate, and tybamate in relation to clinical effects. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _c |
||
| 300 |
_a204-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aBehavior _xdrug effects |
| 650 | 0 | 4 |
_aCarbamates _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDepression, Chemical |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMeprobamate _xadministration & dosage |
| 650 | 0 | 4 |
_aPentobarbital _xadministration & dosage |
| 650 | 0 | 4 | _aSleep |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aClyde, D J | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 9 _gno. 2 _gp. 204-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cpt196892204 _zAvailable from publisher's website |
| 999 |
_c4870906 _d4870906 |
||